Market Overview

Benzinga's Top Downgrades

Related LHCG
Home Health Care Stocks In Play Following Gentiva/Kindred Deal
Top 4 Small-Cap Stocks In The Money Center Banks Industry With The Highest Profit Margin
Related GEVA
Synageva Shares Tumble Amid Positive Phase 3 Data, A Director's 75% Gain & Analyst Concerns
Dow Flirts With 17,000, S&P 500 Inches Closer To 2,000 In First Trading Day Of The Third Quarter

Analysts at Deutsche Bank downgraded LHC Group (NASDAQ: LHCG) from “buy” to “hold.” The target price for LHC Group is set to $23. LHC Group's shares closed at $23.36 yesterday.

Analysts at JP Morgan downgraded Synageva BioPharma (NASDAQ: GEVA) from “overweight” to “neutral.” The target price for Synageva BioPharma has been lowered from $57 to $50. Synageva BioPharma's shares closed at $45.79 yesterday.

Analysts at Canaccord Genuity downgraded Rent-A-Center (NASDAQ: RCII) from “buy” to “hold.” The target price for Rent-A-Center has been lowered from $42.00 to $37.00. Rent-A-Center's shares closed at $35.80 yesterday.

McNicoll Lewis Vlak downgraded Transcept Pharmaceuticals (NASDAQ: TSPT) from “buy” to “hold.” The target price for Transcept Pharmaceuticals is set to $3. Transcept Pharmaceuticals' shares closed at $3.09 yesterday.

Latest Ratings for LHCG

DateFirmActionFromTo
Aug 2014Credit SuisseMaintainsUnderperform
Aug 2014OppenheimerMaintainsOutperform
Mar 2014RBC CapitalUpgradesUnderperformSector Perform

View More Analyst Ratings for LHCG
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (LHCG + GEVA)

Around the Web, We're Loving...

Get Benzinga's Newsletters